These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Percutaneous transluminal coronary angioplasty. The determination of its place and the outlook]. Hamm CW; Bleifeld W Dtsch Med Wochenschr; 1991 Jun; 116(23):905-8. PubMed ID: 2040210 [No Abstract] [Full Text] [Related]
4. [Development of intervention therapy for coronary disease in China: in retrospect and in prospect]. Jia GL Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(31):2161-2. PubMed ID: 16321173 [No Abstract] [Full Text] [Related]
5. Prognostic significance of coronary collaterals in patients with coronary heart disease having percutaneous transluminal coronary angioplasty. Koerselman J; de Jaegere PP; Verhaar MC; Grobbee DE; van der Graaf Y; Am J Cardiol; 2005 Aug; 96(3):390-4. PubMed ID: 16054465 [TBL] [Abstract][Full Text] [Related]
6. Total occlusion: old vs. new technology. Turi ZG Catheter Cardiovasc Interv; 2003 Jun; 59(2):259-60. PubMed ID: 12772254 [No Abstract] [Full Text] [Related]
7. Stents versus bypass grafting for left main coronary artery disease. Tomoda H N Engl J Med; 2008 Jul; 359(4):423-4; author reply 425. PubMed ID: 18655245 [No Abstract] [Full Text] [Related]
9. Percutaneous coronary intervention pharmacology: from a triangle to a square. Dauerman HL J Am Coll Cardiol; 2008 Feb; 51(7):698-700. PubMed ID: 18279732 [No Abstract] [Full Text] [Related]
10. Percutaneous coronary intervention: historical perspectives, current status, and future directions. Arjomand H; Turi ZG; McCormick D; Goldberg S Am Heart J; 2003 Nov; 146(5):787-96. PubMed ID: 14597926 [TBL] [Abstract][Full Text] [Related]
11. Stents versus bypass grafting for left main coronary artery disease. Arnold JR; Banning AP N Engl J Med; 2008 Jul; 359(4):424-5; author reply 425. PubMed ID: 18655246 [No Abstract] [Full Text] [Related]
12. Making angioplasty last longer. Johns Hopkins Med Lett Health After 50; 2001 Oct; 13(8):1-2, 7. PubMed ID: 11591033 [No Abstract] [Full Text] [Related]
13. Bridging American-Canadian health care outcome differences: is there really a gap? Chang WC; Armstrong PW Can J Cardiol; 2004 Nov; 20(13):1341-2. PubMed ID: 15565198 [No Abstract] [Full Text] [Related]
14. Diffuse coronary disease and atherothrombosis: a rationale for long-term therapy to prevent recurrent ischemic events. Bhatt DL J Invasive Cardiol; 2003 Mar; 15 Suppl B():3B-9B; discussion 9B-10B. PubMed ID: 12724580 [No Abstract] [Full Text] [Related]
15. [Effects of percutaneous transluminal coronary angioplasty and stenting on QT dispersion in patients with coronary heart disease]. Zhang Y; Qi SS; Shen XQ; Zhou SH Hunan Yi Ke Da Xue Xue Bao; 2001 Apr; 26(2):171-2. PubMed ID: 12536661 [TBL] [Abstract][Full Text] [Related]
16. Cardiac allograft vasculopathy in heart transplant patients: pathologic and clinical aspects for angioplasty/stenting. Kobashigawa JA J Am Coll Cardiol; 2006 Aug; 48(3):462-3. PubMed ID: 16875969 [No Abstract] [Full Text] [Related]
18. Platelet function assessment to predict outcomes after coronary interventions: hype or hope? Alfonso F; Angiolillo DJ J Am Coll Cardiol; 2006 Nov; 48(9):1751-4. PubMed ID: 17084244 [No Abstract] [Full Text] [Related]
19. [Percutaneous coronary intervention in patients with multiple diseases is not evidence-based. Risk of increasing long-term mortality because of indication sliding]. Bjessmo S; Van der Linden J; Kjellman U Lakartidningen; 2007 Jun 4-11; 104(23):1780-2. PubMed ID: 17655021 [No Abstract] [Full Text] [Related]
20. Coronary disease. Battler A Timely Top Med Cardiovasc Dis; 2007 Nov; 11():E32. PubMed ID: 18301793 [No Abstract] [Full Text] [Related] [Next] [New Search]